Literature DB >> 7636984

Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters.

A D Yurochko1, T F Kowalik, S M Huong, E S Huang.   

Abstract

During human cytomegalovirus (HCMV) infection, a series of regulated events take place following virus binding and entry into the cell, including the upregulation of cellular transcription factors, such as NF-kappa B, which play an essential role in the viral life cycle. We show here that NF-kappa B message is induced during HCMV infection and that the induction is biphasic, suggesting an initial induction at immediate-early (IE) times and a second round of induction at early times. This hypothesis is supported by experiments using cyclohexamide, which showed that the first tier of induction was drug insensitive, while the second tier was drug sensitive. We then show that virus binding alone is sufficient to stimulate NF-kappa DNA binding activity, supporting its role in the initial induction of NF-kappa B. To begin to elucidate the mechanism(s) for the second tier of NF-kappa B regulation, we examined promoter constructs from the NF-kappa B subunits (p105/p50 and p65) for responsiveness following HCMV infection. HCMV infection transactivated the p105/p50 and p65 promoters. The viral IE proteins (IE1-72, IE2-55, and IE2-86) are expressed during the time we see NF-kappa B induction, so we examined their role in NF-kappa B induction. The IE1-72, IE2-55, and IE2-86 proteins transactivated the p65 promoter, while only the IE2-55 protein transactivated the p105/p50 promoter. The p105/p50 promoter has NF-kappa B sites; therefore, upregulation could also be caused by an autoregulatory mechanism. The p65 promoter, however, has been demonstrated to contain only Sp1 sites. To investigate the potential role of SP1, we examined nuclear extracts from HCMV-infected cells. Here, we show that there is a biphasic increase in SP1 activity during viral infection and that there is apparently an absolute requirement for SP1 in the transactivation of the p65 promoter. In conclusion, we suggest a model in which the initial induction of NF-kappa B occurs through viral modulation of cellular factors and the sustained levels of NF-kappa B induction are regulated by a combination of cellular and viral factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636984      PMCID: PMC189383     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  79 in total

Review 1.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  An in vitro system for human cytomegalovirus immediate early 2 protein (IE2)-mediated site-dependent repression of transcription and direct binding of IE2 to the major immediate early promoter.

Authors:  M P Macias; M F Stinski
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

3.  Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.

Authors:  S Ghosh; D Baltimore
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

4.  Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.

Authors:  P C Cogswell; R I Scheinman; A S Baldwin
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

5.  The NF-kappa B p65 promoter.

Authors:  K Ueberla; Y Lu; E Chung; W A Haseltine
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-03

6.  Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection.

Authors:  T F Kowalik; B Wing; J S Haskill; J C Azizkhan; A S Baldwin; E S Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

7.  I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.

Authors:  P A Ganchi; S C Sun; W C Greene; D W Ballard
Journal:  Mol Biol Cell       Date:  1992-12       Impact factor: 4.138

8.  In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins.

Authors:  K M Klucher; M Sommer; J T Kadonaga; D H Spector
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

9.  Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus.

Authors:  U Zabel; T Henkel; M S Silva; P A Baeuerle
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

10.  The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.

Authors:  M Naumann; F G Wulczyn; C Scheidereit
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  103 in total

1.  Characterization of a human cytomegalovirus with phosphorylation site mutations in the immediate-early 2 protein.

Authors:  Julie A Heider; Yongjun Yu; Thomas Shenk; James C Alwine
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.

Authors:  Indira Jutooru; Gayathri Chadalapaka; Ping Lei; Stephen Safe
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

3.  Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts.

Authors:  D Lembo; G Gribaudo; A Hofer; L Riera; M Cornaglia; A Mondo; A Angeretti; M Gariglio; L Thelander; S Landolfo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Interactions between human cytomegalovirus IE1-72 and cellular p107: functional domains and mechanisms of up-regulation of cyclin E/cdk2 kinase activity.

Authors:  Zhigang Zhang; Shu-Mei Huong; Xin Wang; David Y Huang; Eng-Shang Huang
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

5.  An additional long-term mechanism of NF-κB regulation after cytokine treatment in a human hepatoma cell line.

Authors:  Patricia Kohlhof
Journal:  Virchows Arch       Date:  2010-09-23       Impact factor: 4.064

Review 6.  Is HCMV a tumor promoter?

Authors:  Liliana Soroceanu; Charles S Cobbs
Journal:  Virus Res       Date:  2010-10-29       Impact factor: 3.303

7.  Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway.

Authors:  D Gregory; D Hargett; D Holmes; E Money; S L Bachenheimer
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells.

Authors:  Edward P Browne; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

9.  Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein.

Authors:  Eung-Soo Hwang; Zhigang Zhang; Haobin Cai; David Y Huang; Shu-Mei Huong; Chang-Yong Cha; Eng-Shang Huang
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

10.  Analysis of splice variants of the immediate-early 1 region of human cytomegalovirus.

Authors:  Sita Awasthi; Jennifer A Isler; James C Alwine
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.